NCT04699864Terminated
Evaluation of NeoRetina Artificial Intelligence Algorithm for the Screening of Diabetic Retinopathy at the CHUM
The Use of Artificial Intelligence in the Early Detection and the Follow-Up of Diabetic Retinopathy of Diabetic Patients Followed at the CHUM: Evaluation of NeoRetina Automated Algorithm (DIAGNOS Inc.)
Source: ClinicalTrials.gov · Last updated 8 Jul 2026
Brief summary (registry, in English)
This prospective study aims to validate if NeoRetina, an artificial intelligence algorithm developped by DIAGNOS Inc. and trained to automatically detect the presence of diabetic retinopathy (DR) by the analysis of macula centered eye fundus photographies, can detect this disease and grade its severity.
- Status (registry)
- Terminated
- Study type
- Interventional
- Enrollment
- 24 (actual)
- First submitted
- 16 Dec 2020
- Start date
- 10 Jun 2024
- Primary completion date
- 1 Jul 2026
- Lead sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- NCT number
- NCT04699864
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Patients less than 18 years old;
- Patient who already had a treatment (surgery, laser, injection, etc.) for any retinal condition : Age-related macular degeneration (AMD), retinal vascular occlusion (RVO); etc.
Other
- Inability to provide informed consent;
Who the study is looking for
- Patients of 18 years old and older;
- Ability to provide informed consent;
- Diagnostic for diabetes : 3a) Type 1 diabetes of a lest 5 years of evolution; or 3b) Type 2 diabetes;
- Diabetic patient followed and refered by a physician of the Centre hospitalier de l'Université de Montréal (CHUM) : 4a) followed by an endocrinologist of the CHUM; or 4b) hospitalized at the CHUM; or 4c) on the waiting list of the Ophthalmology Clinic of the CHUM for the evaluation of DR.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier de l'Université de Montréal | Montreal | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.